Professor Ona's laboratory at Kyushu University has developed high sensitive, label-free and non-invasive cell-based sensing technology for prediction of anti-cancer and anti-metabolic syndrome compounds in their physiological concentrations.
Subscribe to our email newsletter
This technology determines the efficacy of dynamic cellular reaction against target compounds within one hour after the compound is added.
According to the comany, the method will contribute to compound screening for personalized chemotherapy or preventive medicines including anti-cancer, Alzheimer disease, aging (skin care), diabetes, pro-fat burning, metabolism, hair restoration and body temperature.
Kyushu University Professor Toshihiro Ona said they developed surface plasmon resonance sensor (SPR), for biomolecular interaction analysis, besides establishing the method for mitochondrial membrane potential monitor.
The university intends to set up a venture business to manufacture and sell a multi-sample device, to sell patent for interactive combination of compounds.
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.